Skip to main content
SpringerLink
Log in

What the Future Holds for Resistance in Developing Countries

  • Chapter
  • First Online:
Antimicrobial Resistance in Developing Countries

Abstract

The challenge to controlling antimicrobial resistance in coming years is to put into practice recent policy and programmatic advances. Increasing attention to the problem of antimicrobial resistance, and how resistance in developing countries can affect industrialized countries, has led to increased attention to the problem of resistance in developing countries.

Efforts, however, have lagged behind good intentions. Inappropriate use of antimicrobials, thought to be the major driver of resistance, remains the norm rather than the exception in most of the developing world, as well as in many industrialized countries. Enhanced educational outreach to both consumers and health-care providers to change the pattern of antimicrobial use is crucial and methods to do this effectively have been developed. There is an urgent need for greater regulation of antimicrobial distribution and sale so that private shops staffed by untrained owners and employees are no longer a common source of antimicrobials. Greater management capacity is required to ensure adherence to regulations, to audit prescribing in both the public and the private sectors, and to control corrupt practices and the proliferation of counterfeit or sub-standard drugs. Implementing and sustaining resistance surveillance systems that will alert the medical and public health communities to changes in resistance is also crucial. Development and introduction of rapid techniques to determine infecting pathogens and their susceptibility should enhance both surveillance and care.

The substantial funding that is now flowing to targeted diseases – HIV and AIDS, tuberculosis, and malaria, all three of which have substantial problems with antimicrobial resistance – can in the coming years be both a boon (if funds are used to enhance infrastructure to manage all diseases of public health concern) and a detriment (if efforts remain narrowly focused on these diseases) to controlling resistance. Efforts to reduce disease burden – through health interventions such as immunizations and improved socioeconomic conditions – have the potential to have profound effects on the burden of resistance. Ultimately, control of resistance will depend on an integrated, multidimensional effort, the components of which can be implemented if the commitment, political will, and resources are made available.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adeyi O., Chellaraj G., Goldstein E., Preker A. and Ringold D. 1997. Health status during the transition in Central and Eastern Europe: development in reverse? Health Policy Plan 12:132–145

    Article  CAS  PubMed  Google Scholar 

  • Andre F. E., Booy R., Bock H. L., Clemens J., Datta S. K., John T. J., Lee B. W., Lolekha S., Peltola H., Ruff T. A., Santosham M. and Schmitt H. J. 2008. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 86:140–146

    Article  CAS  PubMed  Google Scholar 

  • Bennett D. E., Bertagnolio S., Sutherland D. and Gilks C. F. 2008. The World Health Organization’s global strategy for prevention and assessment of HIV drug resistance. Antivir Ther 13 Suppl 2:1–13

    PubMed  Google Scholar 

  • Carter G. M., Newhouse J. P. and Relles D. A. 1990. How much change in the case mix index is DRG creep? J Health Econ 9:411–428

    Article  CAS  PubMed  Google Scholar 

  • Cherian T. 2007. WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26–27 October 2006, Geneva. Vaccine 25:6557–6564

    Article  PubMed  Google Scholar 

  • Chetley A., Hardon A., Hodgkin C. and Haaland A. 2007 How to improve the use of medicines by consumers World Health Organization Geneva http://www.who.int/medicines/publications/WHO_PSM_PAR_2007.2.pdf Accessed August 22 2008

  • Chowdhury E. K., El Arifeen S., Rahman M., Hoque D. E., Hossain M. A., Begum K., Siddik A., Begum N., Rahman Q. S., Akter T., Haque T. M., Al-Helal Z. M., Baqui A. H., Bryce J. and Black R. E. 2008. Care at first-level facilities for children with severe pneumonia in Bangladesh: a cohort study. Lancet 372:822–830

    Google Scholar 

  • Coenen S., Michiels B., Renard D., Denekens J. and Van Royen P. 2006. Antibiotic prescribing for acute cough: the effect of perceived patient demand. Br J Gen Pract 56:183–190

    PubMed  Google Scholar 

  • Dong L., Yan H. and Wang D. 2008. Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China. J Antimicrob Chemother 62:410–415

    Article  CAS  PubMed  Google Scholar 

  • Drechsler D. and Jutting J. 2007. Different countries, different needs: the role of private health insurance in developing countries. J Health Polit Policy Law 32:497–534

    Article  PubMed  Google Scholar 

  • El-Sadr W. M. and Hoos D. 2008. The president’s emergency plan for AIDS relief – is the emergency over? N Engl J Med 359:553–555

    Article  CAS  PubMed  Google Scholar 

  • Finch R. G., Metlay J. P., Davey P. G. and Baker L. J. 2004. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 4:44–53

    Article  PubMed  Google Scholar 

  • Geissbuhler A., Bagayoko C. O. and Ly O. 2007. The RAFT network: 5 years of distance continuing medical education and tele-consultations over the Internet in French-speaking Africa. Int J Med Inform 76:351–356

    Article  PubMed  Google Scholar 

  • Girosi F., Olmsted S. S., Keeler E., Hay Burgess D. C., Lim Y. W., Aledort J. E., Rafael M. E., Ricci K. A., Boer R., Hilborne L., Derose K. P., Shea M. V., Beighley C. M., Dahl C. A. and Wasserman J. 2006. Developing and interpreting models to improve diagnostics in developing countries. Nature 444 Suppl 1:3–8

    Article  PubMed  Google Scholar 

  • Greene J. M., Plunkett G., 3rd, Burland V., Glasner J., Cabot E., Anderson B., Neeno-Eckwall E., Qiu Y., Mau B., Rusch M., Liss P., Hampton T., Pot D., Shaker M., Shaull L., Shetty P., Shi C., Whitmore J., Wong M., Zaremba S., Blattner F. R. and Perna N. T. 2007. A new asset for pathogen informatics – the Enteropathogen Resource Integration Center (ERIC), an NIAID Bioinformatics Resource Center for Biodefense and Emerging/Re-emerging Infectious Disease. Adv Exp Med Biol 603:28–42

    Article  PubMed  Google Scholar 

  • Greenwood B. M., Fidock D. A., Kyle D. E., Kappe S. H., Alonso P. L., Collins F. H. and Duffy P. E. 2008. Malaria: progress, perils, and prospects for eradication. J Clin Invest 118:1266–1276

    Article  CAS  PubMed  Google Scholar 

  • Gul H., Omurtag G., Clark P. M., Tozan A. and Ozel S. 2007. Nonprescription medication purchases and the role of pharmacists as healthcare workers in self-medication in Istanbul. Med Sci Monit 13:PH9–PH14

    Google Scholar 

  • Hadi U., Duerink D. O., Lestari E. S., Nagelkerke N. J., Keuter M., Huis In’t Veld D., Suwandojo E., Rahardjo E., van den Broek P. and Gyssens I. C. 2008a. Audit of antibiotic prescribing in two governmental teaching hospitals in Indonesia. Clin Microbiol Infect 14:698–707

    Google Scholar 

  • Hadi U., Keuter M., van Asten H. and van den Broek P. 2008b. Optimizing antibiotic usage in adults admitted with fever by a multifaceted intervention in an Indonesian governmental hospital. Trop Med Int Health 13:888–899

    Google Scholar 

  • Hanif M., Mobarak M. R., Ronan A., Rahman D., Donovan J. J., Jr. and Bennish M. L. 1995. Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic. BMJ 311:88–91

    CAS  PubMed  Google Scholar 

  • Hartwig K., Pashman J., Cherlin E., Dale M., Callaway M., Czaplinski C., Wood W. E., Abebe Y., Dentry T. and Bradley E. H. 2008. Hospital management in the context of health sector reform: a planning model in Ethiopia. Int J Health Plann Manage 23:203–218

    Article  PubMed  Google Scholar 

  • Holmström K., Gräslund S., Wahlström A., Poungshompo S., Bengtsson B.-E. and Kautsky N. 2003. Antibiotic use in shrimp farming and implications for environmental impacts and human health. Int J Food Sci Technol 38:255–266

    Article  Google Scholar 

  • Hsia D. C., Krushat W. M., Fagan A. B., Tebbutt J. A. and Kusserow R. P. 1988. Accuracy of diagnostic coding for Medicare patients under the prospective-payment system. N Engl J Med 318:352–355

    Article  CAS  PubMed  Google Scholar 

  • Jacobs M. R. 2003. Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr Infect Dis J 22:S109–S119

    Article  PubMed  Google Scholar 

  • Koplan J. 2001. CDC’s strategic plan for bioterrorism preparedness and response. Public Health Rep 116 Suppl 2:9–16

    Article  PubMed  Google Scholar 

  • Lim Y. W., Steinhoff M., Girosi F., Holtzman D., Campbell H., Boer R., Black R. and Mulholland K. 2006. Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics. Nature 444 Suppl 1:9–18

    Article  PubMed  Google Scholar 

  • Lord Soulsby of Swaffham Prior 2008. The 2008 Garrod Lecture: antimicrobial resistance – animals and the environment. J Antimicrob Chemother 62:229–233

    Article  Google Scholar 

  • MDG Africa Steering Group 2008 Achieving the Millennium Development Goals in Africa. Recommendations of the MDG Africa Steering Group June 2008 United Nations New York City http://www.mdgafrica.org/pdf/MDG%20Africa%20Steering%20Group%20Recommendations%20-%20English%20-%20HighRes.pdf Accessed August 25 2008

  • Morris S. K., Moss W. J. and Halsey N. 2008. Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis 8:435–443

    Article  CAS  PubMed  Google Scholar 

  • Moszynski P. 2008. Alliance aims to help health workers in poor countries challenge corruption, excessive pricing, and waste of drugs. Bmj 336:1155

    Article  PubMed  Google Scholar 

  • Okeke I. N., Klugman K. P., Bhutta Z. A., Duse A. G., Jenkins P., O’Brien T. F., Pablos-Mendez A. and Laxminarayan R. 2005b. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis 5:568–580

    Google Scholar 

  • Okeke I. N., Laxminarayan R., Bhutta Z. A., Duse A. G., Jenkins P., O’Brien T. F., Pablos-Mendez A. and Klugman K. P. 2005a. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 5:481–493

    Google Scholar 

  • Ooms G., Van Damme W., Baker B. K., Zeitz P. and Schrecker T. 2008. The ‘diagonal’ approach to Global Fund financing: a cure for the broader malaise of health systems? Global Health 4:6

    Article  PubMed  Google Scholar 

  • Paphassarang C., Philavong K., Boupha B. and Blas E. 2002. Equity, privatization and cost recovery in urban health care: the case of Lao PDR. Health Policy Plan 17:72–84

    Article  PubMed  Google Scholar 

  • Planta M. B. 2007. The role of poverty in antimicrobial resistance. J Am Board Fam Med 20:533–539

    Article  PubMed  Google Scholar 

  • Reddy S. G. 2008. Death in China: market reforms and health. Int J Health Serv 38:125–141

    Article  PubMed  Google Scholar 

  • Richet H. M., Mohammed J., McDonald L. C. and Jarvis W. R. 2001. Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis 7:319–322

    Article  CAS  PubMed  Google Scholar 

  • Ritchie M. R. 2007. Use of herbal supplements and nutritional supplements in the UK: what do we know about their pattern of usage? Proc Nutr Soc 66:479–482

    Article  CAS  PubMed  Google Scholar 

  • Rupp R. E., Stanberry L. R. and Rosenthal S. L. 2005. Vaccines for sexually transmitted infections. Pediatr Ann 34:818–820, 822–814

    PubMed  Google Scholar 

  • Ryan M., Griffin S., Chitah B., Walker A. S., Mulenga V., Kalolo D., Hawkins N., Merry C., Barry M. G., Chintu C., Sculpher M. J. and Gibb D. M. 2008. The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. AIDS 22:749–757

    Article  PubMed  Google Scholar 

  • Shekelle P., Maglione M., Geotz M. B., Wagner G., Wang Z., Hilton L., Carter J., Chen S., Tringle C., Mojica W. and Newberry S. 2007. Antiretroviral (ARV) drug resistance in the developing world. Evid Rep Technol Assess (Full Rep) 156:1–74

    Google Scholar 

  • Simonsen G. S., Tapsall J. W., Allegranzi B., Talbot E. A. and Lazzari S. 2004. The antimicrobial resistance containment and surveillance approach – a public health tool. Bull World Health Organ 82:928–934

    PubMed  Google Scholar 

  • Sinha T., Ranson M. K., Chatterjee M. and Mills A. 2007. Management initiatives in a community-based health insurance scheme. Int J Health Plann Manage 22:289–300

    Article  PubMed  Google Scholar 

  • Smith R. D. and Coast J. 2002. Antimicrobial resistance: a global response. Bull World Health Organ 80:126–133

    PubMed  Google Scholar 

  • Stelling J. M. and O’Brien T. F. 1997. Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis 24 Suppl 1:S157–168

    PubMed  Google Scholar 

  • Stenson B., Syhakhang L., Eriksson B. and Tomson G. 2001a. Real world pharmacy: assessing the quality of private pharmacy practice in the Lao People’s Democratic Republic. Soc Sci Med 52:393–404

    Google Scholar 

  • Stenson B., Syhakhang L., Lundborg C. S., Eriksson B. and Tomson G. 2001b. Private pharmacy practice and regulation. A randomized trial in Lao P.D.R. Int J Technol Assess Health Care 17:579–589

    Google Scholar 

  • Tenover F. C., Mohammed M. J., Stelling J., O’Brien T. and Williams R. 2001. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization’s external quality assurance system for antimicrobial susceptibility testing. J Clin Microbiol 39:241–250

    Article  CAS  PubMed  Google Scholar 

  • Thiam S., LeFevre A. M., Hane F., Ndiaye A., Ba F., Fielding K. L., Ndir M. and Lienhardt C. 2007. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA 297:380–386

    Article  CAS  PubMed  Google Scholar 

  • UNICEF 2007 The State of the World’s Children 2008 http://www.unicef.org/publications/files/The_State_of_the_Worlds_Children_2008.pdf Dated Accessed August 18, 2008

  • United Nations Statistics Division Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings http://unstats.un.org/unsd/methods/m49/m49regin.htm#developed Dated Accessed August 18

  • Victora C. G., Huicho L., Amaral J. J., Armstrong-Schellenberg J., Manzi F., Mason E. and Scherpbier R. 2006. Are health interventions implemented where they are most needed? District uptake of the integrated management of childhood illness strategy in Brazil, Peru and the United Republic of Tanzania. Bull World Health Organ 84:792–801

    Article  CAS  PubMed  Google Scholar 

  • Volpato D. E., de Souza B. V., Dalla Rosa L. G., Melo L. H., Daudt C. A. and Deboni L. 2005. Use of antibiotics without medical prescription. Braz J Infect Dis 9:288–291

    Article  PubMed  Google Scholar 

  • Wenzel R. P. 2004. The antibiotic pipeline – challenges, costs, and values. N Engl J Med 351:523–526

    Article  CAS  PubMed  Google Scholar 

  • Wilkins K., Nsubuga P., Mendlein J., Mercer D. and Pappaioanou M. 2008. The Data for Decision Making project: assessment of surveillance systems in developing countries to improve access to public health information. Public Health 122:914–922

    Google Scholar 

  • Ybarra M. L. and Bull S. S. 2007. Current trends in Internet- and cell phone-based HIV prevention and intervention programs. Curr HIV/AIDS Rep 4:201–207

    Article  PubMed  Google Scholar 

  • Zhang R., Eggleston K., Rotimi V. and Zeckhauser R. J. 2006. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2:6

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mpilonhle, Mtubatuba, South Africa

    Michael L. Bennish

  2. Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Michael L. Bennish

  3. CSD, International Centre for Diarrheal Disease Research, Dhaka, Mohakhali, Bangladesh

    Wasif Ali Khan

Authors
  1. Michael L. Bennish
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wasif Ali Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael L. Bennish .

Editor information

Editors and Affiliations

  1. Advisor Alliance for the Prudent Use of, Tufts University, Kneeland St. 75, Boston, 02111, U.S.A.

    Aníbal de J. Sosa

  2. Dept. Zoology, Makerere University Kampala, Kampala, Uganda

    Denis K. Byarugaba

  3. Fundación Lusara, Playa Rosarito 353, Mexico, 08810, Mexico

    Carlos F. Amábile-Cuevas

  4. Depts. Laboratory Medicine, National Taiwan Univ. Hosp., Taipei, Taiwan R.O.C.

    Po-Ren Hsueh

  5. Centre for Microbiology Research, Kenya Medical Research Institute (KEMRI), Nairobi, 00100, Kenya

    Samuel Kariuki

  6. Dept. Biology, Haverford College, Lancaster Avenue 370, Haverford, 19041, U.S.A.

    Iruka N. Okeke

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bennish, M.L., Khan, W.A. (2010). What the Future Holds for Resistance in Developing Countries. In: Sosa, A., Byarugaba, D., Amábile-Cuevas, C., Hsueh, PR., Kariuki, S., Okeke, I. (eds) Antimicrobial Resistance in Developing Countries. Springer, New York, NY. https://doi.org/10.1007/978-0-387-89370-9_4

Download citation

Publish with us

Policies and ethics

Search

Navigation